Conditions: Diabetes Diabetes Mellitus, Type 2
Allocation: NON_RANDOMIZED | Intervention model: SINGLE_GROUP
Enrollment: 87
Healthy volunteers: no

Brief summary:
This trial is conducted in Asia. This trial aims for evaluating the glycaemic control, measured as glycosylated haemoglobin (Hb1Ac), of once daily insulin detemir as an add-on to oral antidiabetic drug (OAD) in subjects with type 2 diabetes mellitus in Korea.

Detailed description:

Arms:
arm 1: None

Interventions: intervention 1: insulin detemir
Intervention descriptions: intervention 1: Treat-to-target dose titration scheme, once daily, injected s.c. (under the skin).

Protocol document: